info@marketresearchfuture.com   đź“ž  +1 (855) 661-4441(US)   đź“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Medical Devices Reimbursement Market Research Report Information By Payer (Public and Private), By Healthcare Setting (Hospitals, Outpatient Facilities and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032


ID: MRFR/HC/10860-HCR | 128 Pages | Author: Kinjoll Dey| November 2024

Medical Devices Reimbursement Market Segmentation


Medical Devices Reimbursement Payer Outlook (USD Billion, 2018-2032)



  • Public

  • Private


Medical Devices Reimbursement Healthcare Setting Outlook (USD Billion, 2018-2032)



  • Hospitals

  • Outpatient Facilities

  • Others


Medical Devices Reimbursement Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)


    • North America Medical Devices Reimbursement by Payer

      • Public

      • Private




    • North America Medical Devices Reimbursement by Healthcare Setting

      • Hospitals

      • Outpatient Facilities

      • Others




    • US Outlook (USD Billion, 2018-2032)


    • US Medical Devices Reimbursement by Payer

      • Public

      • Private




    • US Medical Devices Reimbursement by Healthcare Setting

      • Hospitals

      • Outpatient Facilities

      • Others




    • CANADA Outlook (USD Billion, 2018-2032)


    • CANADA Medical Devices Reimbursement by Payer

      • Public

      • Private




    • CANADA Medical Devices Reimbursement by Healthcare Setting

      • Hospitals

      • Outpatient Facilities

      • Others




    • Europe Outlook (USD Billion, 2018-2032)


      • Europe Medical Devices Reimbursement by Payer

        • Public

        • Private




      • Europe Medical Devices Reimbursement by Healthcare Setting

        • Hospitals

        • Outpatient Facilities

        • Others




      • Germany Outlook (USD Billion, 2018-2032)


      • Germany Medical Devices Reimbursement by Payer

        • Public

        • Private




      • Germany Medical Devices Reimbursement by Healthcare Setting

        • Hospitals

        • Outpatient Facilities

        • Others



      • France Outlook (USD Billion, 2018-2032)


      • France Medical Devices Reimbursement by Payer

        • Public

        • Private




      • France Medical Devices Reimbursement by Healthcare Setting

        • Hospitals

        • Outpatient Facilities

        • Others




      • UK Outlook (USD Billion, 2018-2032)


      • UK Medical Devices Reimbursement by Payer

        • Public

        • Private




      • UK Medical Devices Reimbursement by Healthcare Setting

        • Hospitals

        • Outpatient Facilities

        • Others




      • ITALY Outlook (USD Billion, 2018-2032)


      • ITALY Medical Devices Reimbursement by Payer

        • Public

        • Private




      • ITALY Medical Devices Reimbursement by Healthcare Setting

        • Hospitals

        • Outpatient Facilities

        • Others




      • SPAIN Outlook (USD Billion, 2018-2032)


      • Spain Medical Devices Reimbursement by Payer

        • Public

        • Private




      • Spain Medical Devices Reimbursement by Healthcare Setting

        • Hospitals

        • Outpatient Facilities

        • Others




      • Rest Of Europe Outlook (USD Billion, 2018-2032)


      • Rest Of Europe Medical Devices Reimbursement by Payer

        • Public

        • Private




      • REST OF EUROPE Medical Devices Reimbursement by Healthcare Setting

        • Hospitals

        • Outpatient Facilities

        • Others




      • Asia-Pacific Outlook (USD Billion, 2018-2032)


        • Asia-Pacific Medical Devices Reimbursement by Payer

          • Public

          • Private




        • Asia-Pacific Medical Devices Reimbursement by Healthcare Setting

          • Hospitals

          • Outpatient Facilities

          • Others




        • China Outlook (USD Billion, 2018-2032)


        • China Medical Devices Reimbursement by Payer

          • Public

          • Private




        • China Medical Devices Reimbursement by Healthcare Setting

          • Hospitals

          • Outpatient Facilities

          • Others




        • Japan Outlook (USD Billion, 2018-2032)


        • Japan Medical Devices Reimbursement by Payer

          • Public

          • Private




        • Japan Medical Devices Reimbursement by Healthcare Setting

          • Hospitals

          • Outpatient Facilities

          • Others




        • India Outlook (USD Billion, 2018-2032)


        • India Medical Devices Reimbursement by Payer

          • Public

          • Private




        • India Medical Devices Reimbursement by Healthcare Setting

          • Hospitals

          • Outpatient Facilities

          • Others




        • Australia Outlook (USD Billion, 2018-2032)


        • Australia Medical Devices Reimbursement by Payer

          • Public

          • Private




        • Australia Medical Devices Reimbursement by Healthcare Setting

          • Hospitals

          • Outpatient Facilities

          • Others




        • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)


        • Rest of Asia-Pacific Medical Devices Reimbursement by Payer

          • Public

          • Private




        • Rest of Asia-Pacific Medical Devices Reimbursement by Healthcare Setting

          • Hospitals

          • Outpatient Facilities

          • Others




        • Rest of the World Outlook (USD Billion, 2018-2032)


          • Rest of the World Medical Devices Reimbursement by Payer

            • Public

            • Private




          • Rest of the World Medical Devices Reimbursement by Healthcare Setting

            • Hospitals

            • Outpatient Facilities

            • Others




          • Middle East Outlook (USD Billion, 2018-2032)


          • Middle East Medical Devices Reimbursement by Payer

            • Public

            • Private




          • Middle East Medical Devices Reimbursement by Healthcare Setting

            • Hospitals

            • Outpatient Facilities

            • Others




          • Africa Outlook (USD Billion, 2018-2032)


          • Africa Medical Devices Reimbursement by Payer

            • Public

            • Private




          • Africa Medical Devices Reimbursement by Healthcare Setting

            • Hospitals

            • Outpatient Facilities

            • Others




          • Latin America Outlook (USD Billion, 2018-2032)


          • Latin America Medical Devices Reimbursement by Payer

            • Public

            • Private




          • Latin America Medical Devices Reimbursement by Healthcare Setting

            • Hospitals

            • Outpatient Facilities

            • Others











Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER

6.1. Overview

6.2. Public

6.3. Private

7. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING

7.1. Overview

7.2. Hospitals

7.3. Outpatient Facilities

7.4. Others

8. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, BY REGION

8.1. Overview

8.1. North America

8.1.1. US

8.1.2. Canada

8.2. Europe

8.2.1. Germany

8.2.2. France

8.2.3. UK

8.2.4. Italy

8.2.5. Spain

8.2.6. Rest of Europe

8.3. Asia-Pacific

8.3.1. China

8.3.2. India

8.3.3. Japan

8.3.4. South Korea

8.3.5. Australia

8.3.6. Rest of Asia-Pacific

8.4. Rest of the World

8.4.1. Middle East

8.4.2. Africa

8.4.3. Latin America

9. COMPETITIVE LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Medical Devices Reimbursement Market,

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of Number of Developments in the Global Medical Devices Reimbursement Market,

9.7. Key developments and Growth Strategies

9.7.1. New Payer Launch/Service Deployment

9.7.2. Merger & Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix

9.8.1. Sales & Operating Income, 2022

9.8.2. Major Players R&D Expenditure. 2022

10. COMPANY PROFILES

10.1. Aviva

10.1.1. Company Overview

10.1.2. Financial Overview

10.1.3. Payers Offered

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. Nippon Life Insurance

10.2.1. Company Overview

10.2.2. Financial Overview

10.2.3. Payers Offered

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. CVS Health

10.3.1. Company Overview

10.3.2. Financial Overview

10.3.3. Payers Offered

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. WellCare Health Plans, Inc

10.4.1. Company Overview

10.4.2. Financial Overview

10.4.3. Payers Offered

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. BNP Paribas

10.5.1. Company Overview

10.5.2. Financial Overview

10.5.3. Payers Offered

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. Allianz

10.6.1. Company Overview

10.6.2. Financial Overview

10.6.3. Payers Offered

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. Humana Inc

10.7.1. Company Overview

10.7.2. Financial Overview

10.7.3. Payers Offered

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. Cigna

10.8.1. Company Overview

10.8.2. Financial Overview

10.8.3. Payers Offered

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. UnitedHealth Group

10.9.1. Company Overview

10.9.2. Financial Overview

10.9.3. Payers Offered

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. Anthem insurance Companies Inc

10.10.1. Company Overview

10.10.2. Financial Overview

10.10.3. Payers Offered

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

11. APPENDIX

11.1. References

11.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, SYNOPSIS, 2018-2032

TABLE 2 GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 4 GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 5 NORTH AMERICA: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 7 US: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 8 US: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 9 CANADA: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 10 CANADA: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 1 EUROPE: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 2 EUROPE: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 3 GERMANY: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 4 GERMANY: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 5 FRANCE: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 6 FRANCE: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 7 ITALY: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 8 ITALY: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 9 SPAIN: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 10 SPAIN: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 11 UK: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 12 UK: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 13 REST OF EUROPE: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 14 REST OF EUROPE: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 15 ASIA-PACIFIC: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 16 ASIA-PACIFIC: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 17 JAPAN: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 18 JAPAN: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 19 CHINA: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 20 CHINA: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 21 INDIA: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 22 INDIA: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 23 AUSTRALIA: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 24 AUSTRALIA: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 25 SOUTH KOREA: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 26 SOUTH KOREA: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 27 REST OF ASIA-PACIFIC: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 28 REST OF ASIA-PACIFIC: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 29 REST OF THE WORLD: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 30 REST OF THE WORLD: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 31 MIDDLE EAST: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 32 MIDDLE EAST: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 33 AFRICA: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 34 AFRICA: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

TABLE 35 LATIN AMERICA: MEDICAL DEVICES REIMBURSEMENT MARKET, BY PAYER, 2018-2032 (USD BILLION)

TABLE 36 LATIN AMERICA: MEDICAL DEVICES REIMBURSEMENT MARKET, BY HEALTHCARE SETTING, 2018-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET

FIGURE 4 GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, SHARE (%), BY PAYER, 2022

FIGURE 5 GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, SHARE (%), BY HEALTHCARE SETTING, 2022

FIGURE 6 GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 7 NORTH AMERICA: MEDICAL DEVICES REIMBURSEMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 EUROPE: MEDICAL DEVICES REIMBURSEMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 ASIA-PACIFIC: MEDICAL DEVICES REIMBURSEMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 REST OF THE WORLD: MEDICAL DEVICES REIMBURSEMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 12 AVIVA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 13 AVIVA: SWOT ANALYSIS

FIGURE 14 NIPPON LIFE INSURANCE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 NIPPON LIFE INSURANCE: SWOT ANALYSIS

FIGURE 16 BNP PARIBAS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 BNP PARIBAS: SWOT ANALYSIS

FIGURE 18 CVS HEALTH: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 CVS HEALTH: SWOT ANALYSIS

FIGURE 20 WELLCARE HEALTH PLANS INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 WELLCARE HEALTH PLANS INC: SWOT ANALYSIS

FIGURE 22 ALLIANZ: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 ALLIANZ: SWOT ANALYSIS

FIGURE 24 HUMANA INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 HUMANA INC: SWOT ANALYSIS

FIGURE 26 CIGNA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 CIGNA: SWOT ANALYSIS

FIGURE 28 UNITEDHEALTH GROUP: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 UNITEDHEALTH GROUP: SWOT ANALYSIS

FIGURE 30 ANTHEN INSURANCE COMPANIES INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 ANTHEN INSURANCE COMPANIES INC: SWOT ANALYSIS

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.